Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 1176466
Loop profile: 462668
Loop profile: 782553

Keywords

liver injury, liver inflammation, liver caner, immunotherapy

Countries

China

Biography

Dr. Hua Wang is currently a professor in the Institute for Liver Disease at Anhui Medical University. He is also Director at Division of Tumor Immunotherapy in the Department of Oncology, the First Affiliated Hospital of Anhui Medical University. He received his MD and Ph.D from Anhui Medical University and followed by clinical and research training. Dr. Wang pursued his post-doctoral trainings in Dr. Bin Gao's lab at NIAAA/NIH for almost 7 years. His main interest is liver injury and repair. He is the author of more than 100 peer-reviewed publications in the highly prestigious journal including Gastroenterology, Hepatology, Journal of Hepatology and PNAS. In the past several years, he received several grants supporting from national and provincial natural science foundation of China.

Activities

Collapse all

Funding (1)

National Natural Science Foundation of China

Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Hua Wang

Peer review (72 reviews for 29 publications/grants)

Review activity for Acta pharmaceutica sinica B. (6)
Review activity for Advanced functional materials. (1)
Review activity for Advanced science. (4)
Review activity for Biochimica and biophysica acta. (1)
Review activity for Biomedicine & pharmacotherapy. (2)
Review activity for Cell & bioscience. (4)
Review activity for Cell death and disease. (6)
Review activity for Cell host & microbe. (2)
Review activity for Cell reports medicine. (4)
Review activity for Cell reports. (1)
Review activity for Cellular & molecular immunology (3)
Review activity for Clinical nutrition. (1)
Review activity for CMGH. (3)
Review activity for EBioMedicine. (2)
Review activity for EMBO molecular medicine. (1)
Review activity for Free radical biology & medicine. (5)
Review activity for Genes & diseases. (2)
Review activity for Gut (1)
Review activity for Hepatology international. (10)
Review activity for iScience. (1)
Review activity for Metabolism, clinical and experimental. (2)
Review activity for Nature communications (2)
Review activity for Pharmacology & therapeutics. (1)
Review activity for Phytomedicine. (1)
Review activity for Science signaling. (1)
Review activity for Signal transduction and targeted therapy. (2)
Review activity for Small. (1)
Review activity for Trends in molecular medicine. (1)
Review activity for Trends in pharmacological sciences. (1)
How many people are using ORCID?